Atopic dermatitis / eczema
Eczema is a common disorder in the U.S.
Atopic dermatitis, also commonly referred to as eczema, is a chronic skin disorder that usually affects very young children, and may last until adolescence or adulthood.
Atopic dermatitis or eczema causes the skin to turn red, inflamed and itchy, causing a severe urge to scratch. Eczema sufferers’ skin is excessively dry and scaly. Eczema can affect all areas of the skin, but typical locations are the arm and knee bends, wrists, and ankles.
Symptoms of atopic dermatitis can range from mild to severe and can reduce the quality of life significantly – both for the child suffering from the disease and the parents dealing with the child’s nightly scratching attacks.
Eczema is a common disorder. According to a survey of more than 100.000 individuals, representative of the U.S. population, 31.6 million Americans show some eczema symptoms, and at least 17.8 million show symptoms of moderate to severe eczema or atopic dermatitis. Only about one third of the eczema sufferers reported having received an actual diagnosis by a doctor. Many others are undiagnosed and untreated or manage their symptoms with non-prescription remedies.(1)
A study focused on eczema in children found that 10.7% of children in the U.S. suffer from eczema or atopic dermatitis. Eczema rates in children differ by states – with the highest prevalence reported in many of the East Coast states, as well as in Nevada, Utah, and Idaho. Metropolitan living was found to be a significant factor in predicting a higher disease rate. (2)
Dust mite allergens aggravate eczema – and should be avoided
Atopic dermatitis often goes along with other disorders. People affected by eczema often suffer from allergies and allergic asthma. (3) Different studies have shown that coming in contact with dust mite allergens aggravates eczema in sensitized individuals – triggering eczema flare ups or leading to persistent eczema lesions. Patients are getting markedly better when contact with dust mite allergens is avoided. (4 and 5)
Allergo® encasings are an effective barrier against allergens
Allergo® high-tech microfiber fabrics are tested and certified to provide complete allergen retention. This highly effective barrier helps eczema sufferers avoid contact with dust mite allergens in their bed and alleviate or prevent their nightly symptoms. At the same time, Allergo® encasings are highly breathable, creating a pleasant and healthy sleeping climate. This is especially important for eczema sufferers, since a hot and sweaty sleep environment typically intensifies redness and itching.
1) A population-based survey of eczema prevalence in the United States. Hanifin JM, Reed ML; Dermatitis. 2007 Jun; 18(2): 82-91. https://www.ncbi.nlm.nih.gov/pubmed/17498413)
2) Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. Shaw TE, et al, J Invest Dermatol. 2011 Jan;131(1):67-73. https://www.ncbi.nlm.nih.gov/pubmed/20739951)
3) Association between severe eczema in children and multiple comorbid conditions and increased healthcare utilization: a US population-based study. Silverberg JI, Simpson EL. Pediatr Allergy Immunol. 2013 Aug;24(5):476-86. https://www.ncbi.nlm.nih.gov/pubmed/23773154)
4) Atopic dermatitis and aeroallergen contact sensitivity. Adinoff AD, Tellez P, Clark RA. J Allergy Clin Immunol. 1988 Apr;81(4):736-42.
5) Sensitization to aeroallergens in atopic dermatitis patients: association with concomitant allergic diseases; Celakovska J et al. Journal of the European Academy of Dermatology and Venerology; Dec 10 2014.